Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Satsuma Pharmaceuticals, Inc. (STSA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Former 10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 5,914,252 shares
@ $0
Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 06/08/2023 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 13,877 shares
@ $0.91, valued at
$12.6k
Disposed/sold 60,000 options to buy
@ $29, valued at
$1.7M
Disposed/sold 80,000 options to buy
@ $4.6, valued at
$368k
Disposed/sold 190,000 options to buy
@ $3.46, valued at
$657.4k
Disposed/sold 72,340 options to buy
@ $4.56, valued at
$329.9k
Disposed/sold 76,595 options to buy
@ $1.04, valued at
$79.7k
|
|
| 06/08/2023 |
4
| Shah Rajeev M. (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 5,914,252 shares
@ $0.91, valued at
$5.4M
Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 06/08/2023 |
4
| TAKANASHI KEN (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 22,053,581 shares
@ $0.91, valued at
$20.1M
Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 06/08/2023 |
4
| Riebe Michael T (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
Disposed/sold 14,893 options to buy
@ $4.56, valued at
$67.9k
Disposed/sold 12,765 options to buy
@ $1.04, valued at
$13.3k
Disposed/sold 12,765 options to buy
@ $0.9, valued at
$11.5k
|
|
| 06/08/2023 |
4
| Sandoval Elisabeth (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
Disposed/sold 14,893 options to buy
@ $4.56, valued at
$67.9k
|
|
| 06/08/2023 |
4
| Soloway Thomas P (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $27.25, valued at
$545k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 06/08/2023 |
4
| Kollins John A (President and CEO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 305,911 shares
@ $0.91, valued at
$278.4k
Disposed/sold 175,000 options to buy
@ $29, valued at
$5.1M
Disposed/sold 240,000 options to buy
@ $4.6, valued at
$1.1M
Disposed/sold 505,000 options to buy
@ $3.46, valued at
$1.7M
Disposed/sold 276,595 options to buy
@ $4.56, valued at
$1.3M
Disposed/sold 127,659 options to buy
@ $1.04, valued at
$132.8k
Disposed/sold 127,659 options to buy
@ $0.9, valued at
$114.9k
|
|
| 06/08/2023 |
4
| Lukatch Heath (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $27.97, valued at
$559.4k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 06/08/2023 |
4
| KING THOMAS BRAXTON (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
Disposed/sold 14,893 options to buy
@ $4.56, valued at
$67.9k
Disposed/sold 12,765 options to buy
@ $1.04, valued at
$13.3k
Disposed/sold 12,765 options to buy
@ $0.9, valued at
$11.5k
|
|
| 06/08/2023 |
4
| Shin Nippon Biomedical Laboratories, Ltd. (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 22,053,581 shares
@ $0.91, valued at
$20.1M
Bought 8,423,732 shares
@ $0.91, valued at
$7.7M
|
|
| 06/08/2023 |
4
| Harsch Mutya (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $4.48, valued at
$179.2k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| ALBRECHT DETLEF (Chief Medical Officer) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 190,000 options to buy
@ $3.46, valued at
$657.4k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2021 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 2,922 shares
@ $5.42, valued at
$15.8k
|
|
| 11/23/2021 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 3,225 shares
@ $5.44, valued at
$17.5k
Bought 9,979 shares
@ $5.49, valued at
$54.8k
|
|
| 11/12/2021 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 9,622 shares
@ $5.85, valued at
$56.3k
Bought 7,941 shares
@ $6.05, valued at
$48k
|
|
| 11/10/2021 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 560 shares
@ $5.99, valued at
$3.4k
|
|
| 11/08/2021 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 1,400 shares
@ $5.88, valued at
$8.2k
Bought 7,800 shares
@ $5.95, valued at
$46.4k
|
|
| 11/04/2021 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 8,880 shares
@ $5.64, valued at
$50.1k
|
|
| 11/02/2021 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 44,651 shares
@ $5.71, valued at
$255k
|
|
| 10/29/2021 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 39,581 shares
@ $5.45, valued at
$215.7k
Bought 15,082 shares
@ $5.55, valued at
$83.7k
|
|
|
|
|